Pregled bibliografske jedinice broj: 942655
Irinotecan and Δ9-tetrahydrocannabinol interactions in rat liver: A preliminary evaluation using biochemical and genotoxicity markers
Irinotecan and Δ9-tetrahydrocannabinol interactions in rat liver: A preliminary evaluation using biochemical and genotoxicity markers // Molecules, 23 (2018), 6; 1332, 25 doi:10.3390/molecules23061332 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 942655 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Irinotecan and Δ9-tetrahydrocannabinol
interactions in rat liver: A preliminary
evaluation using biochemical and genotoxicity
markers
Autori
Lucić Vrdoljak, Ana ; Fuchs, Nino ; Mikolić, Anja ; Žunec, Suzana ; Brčić Karačonji, Irena ; Jurič, Andreja ; Prester, Ljerka ; Micek, Vedran ; Neuberg, Marijana ; Čanović, Samir ; Mršić, Gordan ; Kopjar, Nevenka
Izvornik
Molecules (1420-3049) 23
(2018), 6;
1332, 25
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
cannabinoid-based preparations ; functional liver impairments ; genotoxicity ; hepatocytes ; liver to body weight ratio ; oxidative stress
Sažetak
There is growing interest regarding the use of herbal preparations based on Cannabis sativa for medicinal purposes, despite the poorly understood interactions of their main constituent Δ9-tetrahydrocannabinol (THC) with conventional drugs, especially cytostatics. The objective of this pilot study was to prove whether the concomitant intake of THC impaired liver function in male Wistar rats treated with the anticancer drug irinotecan (IRI), and evaluate the toxic effects associated with this exposure. IRI was administered once intraperitoneally (at 100 mg/kg of the body weight (b.w.)), while THC was administered per os repeatedly for 1, 3, and 7 days (at 7 mg/kg b.w.). Functional liver impairments were studied using biochemical markers of liver function (aspartate aminotransferase—AST, alanine aminotransferase—ALP, alkaline phosphatase—AP, and bilirubin) in rats given a combined treatment, single IRI, single THC, and control groups. Using common oxidative stress biomarkers, along with measurement of primary DNA damage in hepatocytes, the degree of impairments caused at the cellular level was also evaluated. THC caused a time-dependent enhancement of acute toxicity in IRI-treated rats, which was confirmed by body and liver weight reduction. Although single THC affected ALP and AP levels more than single IRI, the levels of liver function markers measured after the administration of a combined treatment mostly did not significantly differ from control. Combined exposure led to increased oxidative stress responses in 3- and 7-day treatments, compared to single IRI. Single IRI caused the highest DNA damage at all timepoints. Continuous 7-day oral exposure to single THC caused an increased mean value of comet tail length compared to its shorter treatments. Concomitant intake of THC slightly affected the levels of IRI genotoxicity at all timepoints, but not in a consistent manner. Further studies are needed to prove our preliminary observations, clarify the underlying mechanisms behind IRI and THC interactions, and unambiguously confirm or reject the assumptions made herein.
Izvorni jezik
Engleski
Znanstvena područja
Interdisciplinarne prirodne znanosti, Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb,
Klinički bolnički centar Zagreb,
Opća bolnica Zadar
Profili:
Ljerka Prester
(autor)
Ana Lucić Vrdoljak
(autor)
Gordan Mršić
(autor)
Marijana Neuberg
(autor)
Samir Čanović
(autor)
Anja Katić
(autor)
Nevenka Kopjar
(autor)
Irena Brčić Karačonji
(autor)
Andreja Jurič
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE